Identification of circulating microRNAs as potential biomarkers for hepatic necroinflammation in patients with autoimmune hepatitis.

Chisato SaekiJuntaro MatsuzakiMasahiko KurodaKoji FujitaMakiko IchikawaSatoko TakizawaKeiko TakanoTsunekazu OikawaYasuni NakanumaMasayuki SarutaTakahiro OchiyaAkihito Tsubota

Published in: BMJ open gastroenterology (2022)

These circulating miRNAs are suggested to reflect hepatic necroinflammatory activity and serve as AIH-related and treatment-responsive biomarkers. These miRNAs could be beneficial in developing new therapeutic strategies for AIH.

Keyphrases

multiple sclerosis
cancer therapy
drug induced
drug delivery
replacement therapy